Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
670.20B | 678.23B | 630.99B | 572.28B | 514.35B | 497.16B | Gross Profit |
66.22B | 66.74B | 65.61B | 60.62B | 53.64B | 54.49B | EBIT |
24.53B | 24.79B | 24.54B | 21.14B | 20.50B | 21.80B | EBITDA |
33.16B | 32.19B | 29.75B | 28.61B | 26.23B | 26.30B | Net Income Common Stockholders |
17.08B | 15.13B | 13.79B | 12.06B | 12.17B | 12.28B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
72.96B | 77.50B | 85.07B | 83.94B | 77.44B | 77.26B | Total Assets |
378.43B | 381.70B | 386.82B | 381.98B | 335.07B | 334.50B | Total Debt |
33.83B | 37.34B | 57.93B | 73.94B | 61.22B | 64.96B | Net Debt |
-39.13B | -40.16B | -27.14B | -6.90B | -12.59B | -8.95B | Total Liabilities |
230.68B | 231.42B | 244.60B | 250.86B | 212.76B | 219.40B | Stockholders Equity |
145.49B | 149.08B | 139.52B | 128.04B | 118.29B | 111.44B |
Cash Flow | Free Cash Flow | ||||
0.00 | 16.56B | 28.09B | 10.20B | 8.96B | 14.76B | Operating Cash Flow |
0.00 | 20.38B | 31.61B | 14.11B | 12.43B | 19.77B | Investing Cash Flow |
0.00 | -4.03B | -7.20B | -6.77B | -3.87B | -19.29B | Financing Cash Flow |
0.00 | -24.62B | -20.48B | -1.02B | -8.84B | -10.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $140.81B | 16.38 | 6.55% | 3.76% | 2.42% | -13.12% | |
76 Outperform | ¥119.65B | 19.82 | 2.63% | 11.54% | -8.30% | ||
73 Outperform | ¥163.61B | 28.60 | 4.78% | 2.74% | 20.53% | -75.16% | |
68 Neutral | ¥183.04B | 12.10 | 10.34% | 2.99% | 7.49% | 9.71% | |
64 Neutral | €210.72B | 41.21 | 2.07% | 2.03% | 9.85% | -53.97% | |
63 Neutral | $55.24B | 57.62 | 1.87% | 2.04% | 0.10% | -41.21% | |
54 Neutral | $5.38B | 3.31 | -45.11% | 3.29% | 16.82% | 0.04% |
Ship Healthcare Holdings, Inc. has announced the cancellation of 7,319,266 treasury shares, representing 7.20% of its total shares, as part of a strategic move to optimize its capital structure. This cancellation, scheduled for June 30, 2025, will result in the company having no treasury shares, potentially enhancing shareholder value and improving financial metrics.
The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3080.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.
Ship Healthcare Holdings has announced a plan to acquire up to 3,300,000 of its own shares, valued at up to 5 billion yen, as part of its medium-term management plan. This move aims to enhance shareholder returns, improve earnings per share, and achieve a targeted return on equity of 12%, reflecting the company’s strategic focus on balancing growth investments with shareholder returns.
The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3080.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.
Ship Healthcare Holdings, Inc. has announced the adoption of a restricted stock compensation plan aimed at incentivizing its directors to enhance corporate value sustainably and align their interests with shareholders. This plan, which will be proposed at the upcoming General Meeting of Shareholders, involves granting restricted stocks to eligible directors, with a total annual limit of 35,000 shares or ¥60 million in compensation, separate from existing monetary compensation.
The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.
Ship Healthcare Holdings, Inc. announced changes in its executive personnel following a Board of Directors meeting. Hiroshi Yokoyama will be promoted to Executive Vice President, while Hisanori Fujioka will be appointed as a new Executive Officer. These changes are set to take effect on June 27, 2025, pending approval at the Ordinary General Meeting of Shareholders. The restructuring aims to strengthen the company’s leadership and enhance its strategic direction.
The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.
Ship Healthcare Holdings, Inc. announced a resolution to distribute surplus dividends, with a basis date of March 31, 2025, which will be presented to shareholders in June. The company aims to maintain a dividend payout ratio of 30% or more, reflecting its commitment to returning profits while supporting business growth and strengthening management foundations.
The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.
SHIP Healthcare Holdings has announced its new medium-term management plan, ‘SHIP VISION 2030’, which aims to enhance sustainable growth over the next five years. The plan focuses on optimizing group management resources and includes targets for sales growth, operating profit margin, and return on equity. The company plans to allocate significant funds for strategic investments and maintain a progressive dividend payout. Additionally, the plan emphasizes sustainability efforts, aiming to create value by addressing social issues and contributing to a well-being society.
The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.
Ship Healthcare Holdings reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a 7.5% increase in net sales to ¥678,229 million and a 9.6% rise in profit attributable to owners of the parent. Despite a decrease in comprehensive income, the company improved its equity capital ratio to 39.1% and increased its annual dividend to ¥58.00 per share. These results indicate a stable financial performance and a commitment to shareholder returns, positioning the company favorably in the healthcare market.
The most recent analyst rating on (JP:3360) stock is a Buy with a Yen3220.00 price target. To see the full list of analyst forecasts on Ship Healthcare Holdings stock, see the JP:3360 Stock Forecast page.